WeVote
Log In

Bill

Bill

S 5260

A bill to require the Secretary of Health and Human Services to carry out research and data collection to improve the quality of stroke care, and for other purposes.

119th Congress Introduced by Michael Bennet and 8 co-sponsors

HHS would conduct stroke care quality research and expand data collection to inform guidelines, improve performance, and reduce disparities in stroke outcomes.

Introduced in Senate
0
WeVote Research Nonpartisan
Bill Summary · S 5260

Overview

Bill S.5260, introduced in the 119th Congress, aims to improve the quality of stroke care in the United States by directing the Secretary of Health and Human Services (HHS) to conduct targeted research and enhance data collection related to stroke. The measures are designed to inform best practices, identify disparities, and support improvements in clinical care, outcomes, and system-level responses to stroke.

Primary purpose and intent

  • To require the Secretary of Health and Human Services to carry out research on stroke care quality and to strengthen data collection related to stroke.
  • To utilize research findings and data to improve clinical guidelines, health system performance, and patient outcomes in stroke care.

Key provisions and changes

  • Research mandate: The bill directs HHS to conduct or support studies and analyses focused on the quality of stroke care. This may include examining treatment timelines, adherence to evidence-based guidelines, disparities in care, and outcomes across populations and settings.
  • Data collection and surveillance: The bill requires enhanced data collection related to stroke incidents, treatments (e.g., thrombolysis, thrombectomy), outcomes, and quality metrics. This could involve national stroke registries, surveillance systems, or expanded reporting to inform performance measurement.
  • Use of findings: Results from research and data collection would be used to inform policy guidance, clinical guidelines, and potential quality improvement programs. The objective is to translate evidence into practice to reduce morbidity and mortality from stroke.
  • Collaboration and coordination: The bill may encourage coordination with federal agencies, healthcare providers, researchers, and stakeholders to ensure comprehensive data capture and effective dissemination of findings.
  • Reporting and accountability: There would be reporting requirements to Congress or relevant authorities to track progress, identify gaps, and adjust strategies as needed.

Who would be affected

  • Healthcare providers and health systems: Entities involved in stroke care delivery would be impacted through data reporting requirements and potential alignment with updated guidelines.
  • Patients: Improved stroke care quality, faster treatment times, and better outcomes could result from enhanced research and data-informed practices.
  • Federal agencies: HHS and related offices would oversee research activities, data collection efforts, and reporting.
  • Researchers and stakeholders: Academic institutions, professional associations, and patient advocacy groups would engage in data collection, analysis, and dissemination of findings.

Procedural and timeline aspects

  • Status: Read twice and referred to the Senate Committee on Health, Education, Labor, and Pensions after introduction.
  • Introduced: 2026-08-05
  • Next steps: Committee review, potential markup, and subsequent floor consideration. Timelines depend on committee action and legislative scheduling.

Potential impact and considerations

  • Strengthened evidence base: More robust data on stroke care quality could drive improvements in treatment protocols and system performance.
  • Policy guidance: Data-driven insights may lead to updated national guidelines and quality metrics for stroke care.
  • Equity focus: Enhanced data collection can help identify and address disparities in stroke treatment and outcomes across populations.
  • Implementation challenges: Successful execution will require robust data systems, interoperability, privacy protections, and cooperation from healthcare providers.

If you’d like, I can tailor this summary to specific audiences (clinicians, policymakers, or patient advocates) or add hypothetical examples of data metrics and potential guideline changes.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.